| Authors: |
Kapelyukh Y; Cancer Research Division, University of Dundee Medical School, Dundee, United Kingdom., Gabel-Jensen C; Development ADME, Novo Nordisk A/S, Måløv, Denmark., MacLeod AK; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee, United Kingdom., Daniel Coquelin KS; Cancer Research Division, University of Dundee Medical School, Dundee, United Kingdom; Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark., Stojanovski L; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee, United Kingdom., Frame L; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee, United Kingdom., Tavendale A; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee, United Kingdom., Henderson CJ; Cancer Research Division, University of Dundee Medical School, Dundee, United Kingdom., Read KD; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee, United Kingdom., Wolf CR; Cancer Research Division, University of Dundee Medical School, Dundee, United Kingdom. Electronic address: c.r.wolf@dundee.ac.uk., Säll C; Development ADME, Novo Nordisk A/S, Måløv, Denmark. |